SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-156952
Filing Date
2013-04-16
Accepted
2013-04-16 16:52:00
Documents
2
Period of Report
2013-04-26
Effectiveness Date
2013-04-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d513957ddef14a.htm DEF 14A 508949
2 GRAPHIC g513957g43s57.jpg GRAPHIC 10208
  Complete submission text file 0001193125-13-156952.txt   524351
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-52228 | Film No.: 13764478
SIC: 8731 Services-Commercial Physical & Biological Research